NCT05890209View on ClinicalTrials.gov

Optimizing Weight Loss. Can Continuous Glucose Monitoring Play a Role

NAActive, not recruitingINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

July 15, 2024

Study Completion Date

October 15, 2024

Conditions
Weight LossObesity
Interventions
DEVICE

Continuous Glucose Monitoring device

A small wearable transdermal sensor that tracks glucose levels in interstitial fluid by taking measurements at regular and frequent intervals throughout the day and night.

Trial Locations (1)

G128QQ

University of Glasgow, Glasgow

All Listed Sponsors
lead

University of Glasgow

OTHER